Retirement age and the age of onset of Alzheimer's disease: results from the ICTUS study

PLoS One. 2015 Feb 25;10(2):e0115056. doi: 10.1371/journal.pone.0115056. eCollection 2015.


Objectives: To test whether deferred retirement is associated with delayed onset of Alzheimer's disease (AD), and, if so, to determine whether retirement age still predicts the age at onset of AD when two potential biases are considered.

Methods: The study sample was gathered from the Impact of Cholinergic Treatment Use/Data Sharing Alzheimer cohort (ICTUS/DSA), a European study of 1,380 AD patients. Information regarding retirement age, onset of symptoms and covariates was collected at baseline whereas age at diagnosis was gathered from the patient's medical record prior to study entry. Linear mixed models, adjusted for gender, education, occupation, center, country, household income, depression and cardiovascular risk factors were conducted on 815 patients.

Results: (1) The global analyses (n = 815) revealed that later age at retirement was associated with later age at diagnosis (β = 0.31, p < 0.0001); (2) once the selection bias was considered (n = 637), results showed that this association was weaker but remained significant (β = 0.15, p = 0.004); (3) once the bias of the reverse causality (i.e., the possibility that subjects may have left the workforce due to prior cognitive impairment) was considered (n = 447), the effect was no longer significant (β = 0.06, p = 0.18).

Conclusion: The present study supports that there is an association between retirement age and age at onset of AD. However, the strength of this association appears to be overestimated due to the selection bias. Moreover, the causality issue remains unresolved. Further prospective investigations are mandatory in order to correctly address this question.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Age of Onset
  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / epidemiology*
  • Comorbidity
  • Europe
  • Female
  • Humans
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Retirement*

Grants and funding

C. Grotz is supported by the Fund for Scientific Research (F. R. S. – FNRS), Belgium ( The other authors reported no disclosures. The ICTUS study was partially supported by a grant from the European Commission within the 5th framework program (QLK6-CT-2002-02645) and partially from an unrestricted equal grant xeach of Eisai, Jansen, Lundbeck, and Novartis pharmaceutical companies. The pharmaceutical companies had no role in the study design or conduct of the study, data collection, data analysis, data interpretation; or preparation, review, or approval of the manuscript. Promotion of the ICTUS study was supported by the University Hospital Center of Toulouse. The data sharing activity was supported by the “Association Monegasque pour la recherche sur la maladie d’Alzheimer”(AMPA) and the UMR 1027 Unit INSERM–University of Toulouse III.